Issues Archive

The most complete archive of clinical and pathology lab industry news available, including issues from 1997 to the present.

Volume XXVII No. 4 – March 9, 2020

In this issue:

CORONAVIRUS HITS THE LAB INDUSTRY especially hard, and THE DARK REPORT is behind the scenes to document early successes. These include the rapid validation of virus tests and the adaption of a mobile phlebotomy lab program to COVID-19 testing by one lab in the heart of the New York pandemic. In non-COVID-19 news, some commercial payers and state Medicaid programs are not paying for new proprietary laboratory analyses (PLA) codes and multianalyte assays with algorithmic analyses (MAAA) codes.

View Issue TOC

Volume XXVII No. 3 – February 17, 2020

In this issue:

IT’S A TALE OF TWO LABS: One saw the handwriting on the wall and took steps to successfully stay in business by producing value-added outcomes. The other was forced to sell its outreach business to Quest Diagnostics. THE DARK REPORT outlines how each lab responded to pressures on their business to stay afloat. Also included in this issue are the details of how a manager of an opioid treatment center in Kentucky pleaded guilty recently to three counts under EKRA: soliciting a bribe, making a false statement, and attempting to tamper with evidence.

View Issue TOC

Volume XXVII No. 2 – January 27, 2020

In this issue:

THE DARK REPORT EXAMINES how using cheap offshore billing companies might come back to bite clinical labs, which are turning to these companies to cut costs in an increasingly stressful business climate. Also in this issue is an insider look at how 33 industry groups came together to help get the Laboratory Access for Beneficiaries (LAB) Act passed, which will relieve some of the most onerous burdens imposed by Protecting Access to Medicare Act of 2016.

View Issue TOC

Volume XXVII No. 1 – January 6, 2020

In this issue:

WILL CLINICAL LABS BE EXCLUDED from the new proposed safe harbors under the Stark Act and the AKS? THE DARK REPORT analyzes the problem and also the warning that lies within CMS’ plans for revisions to the anti-fraud laws. Also in this issue are key health system strategies and lab objectives from inside the highly successful switch to value-based medicine at one hospital lab, which was once considered a candidate for sale.

View Issue TOC

Volume XXVI No. 17 – December 16, 2019

In this issue:

THE MOST IMPORTANT STORY OF THE YEAR is actually 10 stories. THE DARK REPORT delivers a must-read overview of a turbulent 2019 that delivered mostly bad news, but also some opportunities for those with nimble management feet. Also, in Part 2 of our report on lawsuits filed in federal court against the two national labs, an insider-turned-whistleblower makes revealing allegations about the internal policies governing charging high prices to the uninsured patient.

View Issue TOC

Volume XXVI No. 16 – November 25, 2019

In this issue:

UNDERREPORTED BUT CRITICAL TRENDS dominate this issue of THE DARK REPORT. In one, the evidence shows that ICD-10 codes’ richer data are now giving payers brand new opportunities to reject lab payment claims or even try to claw back payments already made. Also, lawsuits alleging that the Blood Brothers are overcharging uninsured patients might actually be an opportunity for labs to be more competitive with the big national labs.

View Issue TOC

Volume XXVI No. 15 – November 4, 2019

In this issue:

THE DARK REPORT DETAILS THE NEW CMS RULE targeting Medicare fraudsters that could entrap clinical labs and pathology groups. At the same time, attorneys outline ways for labs to navigate this new minefield and avoid problems. Also, an expert details six different ways that labs can use their valuable data — without selling it — to improve patient care and lower healthcare costs, with new revenue streams as a bonus.

View Issue TOC

Volume XXVI No. 14 – October 14, 2019

In this issue:

ALL LABORATORIANS must take heed of the disruptive new trends in the healthcare industry, which will affect the way patients, doctors, labs, payers and others interact with each other. Also, THE DARK REPORT explains how a genetic testing fraud, recently the target of federal prosecutors, was executed by the alleged perpetrators.

View Issue TOC

Volume XXVI No. 13 – September 23, 2019

In this issue:

A MAJOR HEALTH NETWORK is addressing the opioid crisis: Community Health Network of Indianapolis recognized that clinical lab toxicology tests are one of the few sources of objective data about patient compliance, and is using that data in its new Chronic Opioid Therapy program. This first-time intelligence briefing on such a program also includes insights about lessons learned and discusses how offering additional analytical reports and services add value to the health network’s COT patient management program.

View Issue TOC

Volume XXVI No. 12 – September 3, 2019

In this issue:

SOME PATHOLOGISTS AND LAB EXECUTIVES find the FDA’s latest actions regarding pharmacogenetic testing confusing, unclear and beyond the FDA’s authority. Other observers note that the FDA does indeed have a legitimate concern. THE DARK REPORT examines both sides of this controversy. Also reported is the opinion of respected pathology consultants that the result of deep fee cuts by Anthem to some anatomic pathology services will harm patients.

View Issue TOC

Don’t Be at the Mercy of the Tumultuous Healthcare Revolution

Subscribe to The Dark Report for as little as $15.27 per week.

Get the most expert business intelligence for clinical laboratories and pathology groups available today. Subscribe to The Dark Report.

First name*
Last name*
Email*
Job Title*
Company Name*
Phone
Address*
Street Address Address Line 2 City State / Province / Region ZIP / Postal Code Country
You’ll also receive the latest issue of our FREE newsletter, The Dark Report Insider, every three weeks!
Membership Plans*
- Platinum Membership
  
  Get digital and print editions of The Dark Report for only $22.97 per week. Plus a Free bonus Executive Briefing
  Print Edition, Web Edition, and Web Archive
- Digital Membership
  
  Get web access of The Dark Report for only $19.12 per week. Plus a Free bonus Executive Briefing
  Web Edition and Web Archive
- Print Membership
  
  Get a hard copy of The Dark Report delivered to your home for only $15.27 per week. Plus a Free bonus Executive Briefing *Offer valid in the United States and Canada only.
  Print Edition (US & Canada Only)
Name
This field is for validation purposes and should be left unchanged.

CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025

Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.

See the full table of contents

How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Need A Group Membership? Company Discounts are Available!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

Topics

Visit The Dark Library